PropofolVet Multidose contains the same active ingredient as the brand name propofol injectable emulsion, PropoFlo 28 by ...

Adjusted EPS came in at $1.58, topping the consensus estimate of $1.46. Zoetis's Q3 2024 revenue of $2.4 billion beat expectations of $2.28 billion, up 14% year over year. Companion animal ...

Zoetis Inc. (NYSE:ZTS) just released its quarterly report and things are looking bullish. The company beat expectations with revenues of US$2.4b arriving 4.2% ahead of forecasts. Statutory ...

Zoetis (NYSE:ZTS) just turned in another stellar quarter, leaving Wall Street buzzing. The animal health powerhouse reported Q3 revenue of $2.4 billion, up 11% year-over-year, with adjusted net ...

Nov 4 (Reuters) - Zoetis (ZTS.N), opens new tab raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals. Shares of the animal ...

(RTTNews) - Zoetis Inc. (ZTS) revealed earnings for its third quarter that increased from last year and beat the Street estimates. The company's bottom line came in at $682 million, or $1.50 per ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Wetteny Joseph, Executive Vice President ...

(a) For a description of each segment, see Zoetis' most recent Annual Report on Form 10-K. (b) Operational results (a non-GAAP financial measure) is defined as results excluding the impact of ...

Welcome to the Third Quarter 2024 Financial Results Conference Call and Webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis. The presentation ...

In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against Well Fargo’s other growth stocks. With the interest rate cycle kicking off in the US, stocks that are ...

Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on its impressive ...

Investing.com -- Shares in Zoetis (NYSE:ZTS) edged higher in premarket US trading on Monday after the drugmaker reported better-than-anticipated third-quarter earnings and revenue. The New Jersey ...